NBI-1070770

· Neurocrine Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NBI-1070770, covering 2025-10-29 to 2025-10-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of NBI-1070770 in Adults With Major Depressive Disorder [Phase 2]